PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
VALE vs. ABBV
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between VALE and ABBV is 0.15, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.1

Performance

VALE vs. ABBV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Vale S.A. (VALE) and AbbVie Inc. (ABBV). The values are adjusted to include any dividend payments, if applicable.

-20.00%-10.00%0.00%10.00%20.00%AugustSeptemberOctoberNovemberDecember2025
-16.23%
1.88%
VALE
ABBV

Key characteristics

Sharpe Ratio

VALE:

-1.27

ABBV:

0.39

Sortino Ratio

VALE:

-1.96

ABBV:

0.64

Omega Ratio

VALE:

0.78

ABBV:

1.10

Calmar Ratio

VALE:

-0.68

ABBV:

0.49

Martin Ratio

VALE:

-1.91

ABBV:

1.23

Ulcer Index

VALE:

18.42%

ABBV:

7.61%

Daily Std Dev

VALE:

27.71%

ABBV:

23.74%

Max Drawdown

VALE:

-93.21%

ABBV:

-45.09%

Current Drawdown

VALE:

-50.33%

ABBV:

-15.16%

Fundamentals

Market Cap

VALE:

$37.39B

ABBV:

$302.80B

EPS

VALE:

$2.16

ABBV:

$2.86

PE Ratio

VALE:

4.06

ABBV:

59.91

PEG Ratio

VALE:

10.64

ABBV:

0.40

Total Revenue (TTM)

VALE:

$27.94B

ABBV:

$41.23B

Gross Profit (TTM)

VALE:

$9.78B

ABBV:

$30.76B

EBITDA (TTM)

VALE:

$11.24B

ABBV:

$17.62B

Returns By Period

In the year-to-date period, VALE achieves a -1.24% return, which is significantly higher than ABBV's -2.66% return. Over the past 10 years, VALE has underperformed ABBV with an annualized return of 7.03%, while ABBV has yielded a comparatively higher 14.98% annualized return.


VALE

YTD

-1.24%

1M

-3.74%

6M

-18.24%

1Y

-33.07%

5Y*

0.55%

10Y*

7.03%

ABBV

YTD

-2.66%

1M

0.78%

6M

-0.52%

1Y

9.98%

5Y*

19.25%

10Y*

14.98%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

VALE vs. ABBV — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VALE
The Risk-Adjusted Performance Rank of VALE is 44
Overall Rank
The Sharpe Ratio Rank of VALE is 11
Sharpe Ratio Rank
The Sortino Ratio Rank of VALE is 22
Sortino Ratio Rank
The Omega Ratio Rank of VALE is 44
Omega Ratio Rank
The Calmar Ratio Rank of VALE is 99
Calmar Ratio Rank
The Martin Ratio Rank of VALE is 11
Martin Ratio Rank

ABBV
The Risk-Adjusted Performance Rank of ABBV is 6161
Overall Rank
The Sharpe Ratio Rank of ABBV is 6464
Sharpe Ratio Rank
The Sortino Ratio Rank of ABBV is 5353
Sortino Ratio Rank
The Omega Ratio Rank of ABBV is 5656
Omega Ratio Rank
The Calmar Ratio Rank of ABBV is 6969
Calmar Ratio Rank
The Martin Ratio Rank of ABBV is 6363
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

VALE vs. ABBV - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Vale S.A. (VALE) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for VALE, currently valued at -1.27, compared to the broader market-2.000.002.00-1.270.39
The chart of Sortino ratio for VALE, currently valued at -1.96, compared to the broader market-4.00-2.000.002.004.00-1.960.64
The chart of Omega ratio for VALE, currently valued at 0.78, compared to the broader market0.501.001.502.000.781.10
The chart of Calmar ratio for VALE, currently valued at -0.71, compared to the broader market0.002.004.006.00-0.710.49
The chart of Martin ratio for VALE, currently valued at -1.91, compared to the broader market-30.00-20.00-10.000.0010.0020.00-1.911.23
VALE
ABBV

The current VALE Sharpe Ratio is -1.27, which is lower than the ABBV Sharpe Ratio of 0.39. The chart below compares the historical Sharpe Ratios of VALE and ABBV, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00AugustSeptemberOctoberNovemberDecember2025
-1.27
0.39
VALE
ABBV

Dividends

VALE vs. ABBV - Dividend Comparison

VALE's dividend yield for the trailing twelve months is around 11.52%, more than ABBV's 3.67% yield.


TTM20242023202220212020201920182017201620152014
VALE
Vale S.A.
11.52%11.38%7.75%8.65%19.70%2.73%2.63%4.16%3.39%0.64%8.84%6.69%
ABBV
AbbVie Inc.
3.67%3.49%3.82%3.49%3.84%4.41%4.83%3.89%2.65%3.64%3.41%2.54%

Drawdowns

VALE vs. ABBV - Drawdown Comparison

The maximum VALE drawdown since its inception was -93.21%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for VALE and ABBV. For additional features, visit the drawdowns tool.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-48.27%
-15.16%
VALE
ABBV

Volatility

VALE vs. ABBV - Volatility Comparison

Vale S.A. (VALE) has a higher volatility of 7.08% compared to AbbVie Inc. (ABBV) at 5.54%. This indicates that VALE's price experiences larger fluctuations and is considered to be riskier than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%AugustSeptemberOctoberNovemberDecember2025
7.08%
5.54%
VALE
ABBV

Financials

VALE vs. ABBV - Financials Comparison

This section allows you to compare key financial metrics between Vale S.A. and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab